GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Equity-to-Asset

BioPharma Credit (LSE:BPCR) Equity-to-Asset : 0.98 (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BioPharma Credit's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $1,337.5 Mil. BioPharma Credit's Total Assets for the quarter that ended in Dec. 2022 was $1,364.0 Mil. Therefore, BioPharma Credit's Equity to Asset Ratio for the quarter that ended in Dec. 2022 was 0.98.

The historical rank and industry rank for BioPharma Credit's Equity-to-Asset or its related term are showing as below:

LSE:BPCR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.98   Med: 0.99   Max: 1
Current: 0.99

During the past 7 years, the highest Equity to Asset Ratio of BioPharma Credit was 1.00. The lowest was 0.98. And the median was 0.99.

LSE:BPCR's Equity-to-Asset is ranked better than
90.45% of 1727 companies
in the Asset Management industry
Industry Median: 0.82 vs LSE:BPCR: 0.99

BioPharma Credit Equity-to-Asset Historical Data

The historical data trend for BioPharma Credit's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Equity-to-Asset Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.98 0.99 1.00 0.98 0.99

BioPharma Credit Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.00 1.00 0.98 0.99

Competitive Comparison of BioPharma Credit's Equity-to-Asset

For the Asset Management subindustry, BioPharma Credit's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's Equity-to-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's Equity-to-Asset falls into.



BioPharma Credit Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BioPharma Credit's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1340.861/1356.732
=0.99

BioPharma Credit's Equity to Asset Ratio for the quarter that ended in Dec. 2022 is calculated as

Equity to Asset (Q: Dec. 2022 )=Total Stockholders Equity/Total Assets
=1337.453/1364.016
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit  (LSE:BPCR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BioPharma Credit Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit (LSE:BPCR) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines